Das Allgemeine Krankenhaus der Stadt Linz war ein großes städtisches Krankenhaus in Österreichs drittgrößter Stadt Linz. Seit 31. Dezember 2015 ist es als Standort Med Campus III.

During the past decade, Kepler Universitatsklinikum conducted 100 clinical trials. In the 10-year time frame, 100 clinical trials started and 30 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 12 clinical trials were completed. i.e. 35.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kepler Universitatsklinikum" #1 sponsor was "Biotronik SE & Co. KG" with 12 trials, followed by "Kepler University Hospital" with 12 trials sponsored, "Abbott Medical Devices" with 9 trials sponsored, "Boehringer Ingelheim" with 8 trials sponsored and "Boston Scientific Corporation" with 8 trials sponsored. Other sponsors include 110 different institutions and companies that sponsored additional 83 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kepler Universitatsklinikum" #1 collaborator was "Kepler University Hospital" with 4 trials as a collaborator, "Klinikum Klagenfurt am Wörthersee" with 3 trials as a collaborator, "Medical University of Graz" with 3 trials as a collaborator, "Medical University of Vienna" with 3 trials as a collaborator and "Charite University, Berlin, Germany" with 2 trials as a collaborator. Other collaborators include 123 different institutions and companies that were collaborators in the rest 128 trials.

According to Clinical.Site data, the most researched conditions in "Kepler Universitatsklinikum" are "Breast Cancer" (6 trials), "Coronary Artery Disease" (6 trials), "Heart Failure" (6 trials), "Atrial Fibrillation" (5 trials) and "Bradycardia" (4 trials). Many other conditions were trialed in "Kepler Universitatsklinikum" in a lesser frequency.

Most popular intervention types in "Kepler Universitatsklinikum" are "Drug" (64 trials), "Device" (51 trials), "Other" (20 trials), "Procedure" (12 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Carboplatin" (4 trials), "Cerebrolysin" (3 trials), "Etoposide" (3 trials) and "Guselkumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Kepler Universitatsklinikum" are 151 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Kepler Universitatsklinikum". undefined are not yet recruiting, 30 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 83 completed trials in Kepler Universitatsklinikum, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Kepler Universitatsklinikum, 5 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 47 trials that are defined as “Not Applicable".

Kepler Universitatsklinikum has several departments that took part in Clinical trials: "Landesnervenklinik Wagner Jauregg" - 6 trials, "Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie" - 5 trials, "Kepler Universitätsklinikum GmbH - Neuromed Campus; Neurologie" - 3 trials, "Kepler Universitätskliniken GmbH - Med Campus III; Neurologie & Psychiatrie" - 3 trials, "Kepler Universitätsklinikum, Universitätsklinik für Neurochirurgie" - 2 trials, "LNK Wagner-Jauregg, Dept. of geriatrics" - 2 trials, "2nd Surgical Department, Academic Teaching Hospital, AKH Linz" - 2 trials, "Kepleruniversitätsklinikum GmbH, Hämatologie und Internistische Onkologie" - 2 trials